维生素D通过调节肠道微生物群来改善大鼠的克莱布西埃拉引起的严重肺炎
Jia-Jia Hu1, Yu-Sen Lin1, Jing-Cong Zhang1
1Medical Intensive Care Unit, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Infection and drug resistance
|February 13, 2024
概括
维生素D (VD) 治疗改善了Klebsiella pneumoniae (KP) 肺炎的老鼠的生存率和减少了肺损伤. VD还调节了肠道微生物群,增强了对KP感染的抵抗力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素耐药性的增加需要替代性治疗细菌感染.
- 克莱布西拉肺炎 (KP) 引起的肺炎是一个日益增长的治疗挑战.
- 维生素D (VD) 在治疗肺炎方面表现出潜力.
研究的目的:
- 在大鼠模型中研究维生素D (VD) 对Klebsiella pneumoniae (KP) 引起的肺炎的治疗作用.
- 阐明静脉疾病作用的基本机制,包括其对宿主免疫反应和肠道微生物群的影响.
主要方法:
- 建立了一种Klebsiella肺炎 (KP) 肺炎的老鼠模型.
- 通过食,小鼠接受了维生素D (VD) 的治疗.
- 分析了生存率,肺损伤 (含水量,组织病理学),炎症标志物 (TNF-α,IL-1β,MCP1) 和肠道微生物群组成 (16S rDNA测序).
主要成果:
- 维生素D (VD) 治疗显著增加了KP感染大鼠的存活率.
- 肺部疾病降低了肺部的水含量,细菌负载和炎症性细胞因子水平.
- 静脉疾病的管理改变了肠道微生物群的结构,增加了物种丰富性和Anaeroglobus的丰富性.
结论:
- 维生素D (VD) 显示出对Klebsiella pneumoniae (KP) 引起的肺炎具有显著的治疗潜力.
- 维生素D的有效性与其调节肠道微生物群的能力有关,从而增强宿主耐药性.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
13.0K
相关概念视频
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...